诺华去铁药地拉罗司在国内买的到吗？

(Deferasirox) is an iron chelator product developed by Novartis Pharma Schweiz AG in Switzerland. It is a tridentate iron chelator that can form a complex with ferric ions in a ratio of 2:1 and is excreted from the feces, thereby reducing the iron content in the human body.

The Swiss company Novartis is the world leader in pharmaceutical manufacturing and health care product consumption. After nearly two decades of development, it has gradually grown into a leader in the global pharmaceutical field and has contributed to the development of the world's pharmaceutical and health care industry. Its deferasirox has brought new hope to the treatment of many patients. So, is Novartis’ iron-removing medicine deferasirox available in the country?

The answer is yes. Because on June 30, 2010, Novartis' iron-removing drug deferasirox was approved by the State Food and Drug Administration and officially launched in China. Now, patients can buy the drugs they need in China. Not only that, the drug is also included in the scope of medical insurance, and patients can also rely on medical insurance to reimburse part of the cost when purchasing the drug. In addition to purchasing deferasirox domestically, patients can also contact some professional and formal overseas medical service organizations in China (such as Medical Travel) to obtain more cost-effective drugs from abroad.

After purchasing the drug, patients should pay attention: As early as December 13, 2007, Novartis warned medical personnel to pay attention to the revised content of the deferasirox tablet package insert. Post-marketing adverse reaction reports such as liver failure and death were added to the warnings and adverse reactions section. In view of the fact that Deferasirox may cause serious adverse reactions of liver failure, patients must monitor liver function regularly every month while taking the drug. In the event of unexplained, persistent or progressive increases in serum aminotransferase levels, or other serious adverse reactions, the dosage should be adjusted or the drug discontinued.

Recommended hot articles: /newsDetail/92223.html